Factors associated with progression to PSCR and no SCR at end of follow-up
. | Progression to PSCR (analysis on n = 109) . | No SCR at end of follow-up (analysis on n = 126) . | ||
---|---|---|---|---|
Unadjusted OR (95% CI) . | P value . | Unadjusted OR (95% CI) . | P value∗ . | |
Gender | ||||
Male | Reference | Reference | ||
Female | 0.404 (0.126-1.297) | .128 | 2.485 (1.210-5.101) | .013 |
Hb genotype | ||||
HbSS/HbSβ0/HbSβ+ | Reference | 3.726 (1.699-8.169) | ||
HbSC | 5.973 (1.812-19.684) | .003 | Reference | .001 |
Age | ||||
y | 0.988 (95% CI, 0.934-1.045) | .671 | 0.977 (95% CI, 0.946-1.009) | .161 |
HbF | ||||
% | 0.812 (0.663-0.993) | .043 | 1.201 (1.093-1.319) | .001 |
Hb level | ||||
mmol/L | 1.565 (0.883-2.774) | .125 | 0.673 (0.479-0.946) | .022 |
Lactate dehydrogenase | ||||
U/L | 0.997 (0.993-1.000) | .086 | 1.001 (0.999-1.003) | .232 |
Bilirubin | ||||
μmol/L | 1.001 (0.987-1.016) | .856 | 1.003 (0.993-1.013) | .601 |
Reticulocytes | ||||
% | 0.996 (0.882-1.124) | .944 | 1.019 (0.943-1.100) | .640 |
. | Progression to PSCR (analysis on n = 109) . | No SCR at end of follow-up (analysis on n = 126) . | ||
---|---|---|---|---|
Unadjusted OR (95% CI) . | P value . | Unadjusted OR (95% CI) . | P value∗ . | |
Gender | ||||
Male | Reference | Reference | ||
Female | 0.404 (0.126-1.297) | .128 | 2.485 (1.210-5.101) | .013 |
Hb genotype | ||||
HbSS/HbSβ0/HbSβ+ | Reference | 3.726 (1.699-8.169) | ||
HbSC | 5.973 (1.812-19.684) | .003 | Reference | .001 |
Age | ||||
y | 0.988 (95% CI, 0.934-1.045) | .671 | 0.977 (95% CI, 0.946-1.009) | .161 |
HbF | ||||
% | 0.812 (0.663-0.993) | .043 | 1.201 (1.093-1.319) | .001 |
Hb level | ||||
mmol/L | 1.565 (0.883-2.774) | .125 | 0.673 (0.479-0.946) | .022 |
Lactate dehydrogenase | ||||
U/L | 0.997 (0.993-1.000) | .086 | 1.001 (0.999-1.003) | .232 |
Bilirubin | ||||
μmol/L | 1.001 (0.987-1.016) | .856 | 1.003 (0.993-1.013) | .601 |
Reticulocytes | ||||
% | 0.996 (0.882-1.124) | .944 | 1.019 (0.943-1.100) | .640 |
Significant P-values (P < 0.05) are shown in bold.